Intellia Therapeutics NTLA has made meaningful progress with the development of its in vivo programs. The company is currently advancing two late-stage in vivo candidates — lonvo-z (or, NTLA-2002) for ...

The U.S. president's transactional approach to diplomacy could secure access to strategic resources—a trade dominated by ...

Iowa soybean farmers are finding themselves in the crossfire as trade tensions continue to rise between the United States and ...

For All of Us” The PCs earned just enough seats to form a majority government in a stunning upset during the 2025 general ...